Clinical Trials Logo

Automobile Driving clinical trials

View clinical trials related to Automobile Driving.

Filter by:
  • None
  • Page 1

NCT ID: NCT06290037 Recruiting - Automobile Driving Clinical Trials

Driving Ability Evaluation System to Improve the Conditional Driving License System: Feasibility Study of High-risk Drivers.

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

The primary objective of this study is to verify the safety and validity of a VR driving simulator developed for evaluating the driving abilities of elderly drivers. This study also aims to establish indicators in VR driving simulator to evaluate high-risk group for driving, such as cognitive and physical abilities. Therefore, this study aims to measure the physical driving function, general physical function and cognitive function of elderly drivers. to identify the correlation between their outcomes and the VR driving simulator's result

NCT ID: NCT06279520 Recruiting - Automobile Driving Clinical Trials

Driving Ability Evaluation System to Improve the Conditional Driving License System: Safety and Feasibility Study.

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

The primary objective of this study is to verify the safety and validity of a VR driving simulator developed for evaluating the driving abilities in healthy adults. This study also aims to establish indicators in VR driving simulator to evaluate high-risk group for driving, such as cognitive and physical abilities. Therefore, this study aims to measure the physical driving function and cognitive function of healthy drivers. to identify the correlation between their outcomes and the VR driving simulator's result

NCT ID: NCT05163119 Recruiting - Automobile Driving Clinical Trials

Randomized Trial on Mobile Technology and Young Drivers' Cellphone Use

Start date: November 9, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a randomized controlled trial to determine the effects of a cellphone app and a driving mode intervention on driving behavior in drivers aged 18-24 years.

NCT ID: NCT05096000 Enrolling by invitation - Automobile Driving Clinical Trials

InterMob: a Randomized Controlled Trial Aimed at Reducing Car Use in Regular Car Users

InterMob
Start date: September 21, 2021
Phase: N/A
Study type: Interventional

Regular car use is a source of pollution and physical inactivity. InterMob is an interdisciplinary randomized controlled behavioral intervention aiming at reducing car use. The objectives of InterMob are to a) Evaluate the efficacy of a theory- and evidence-based intervention, b) Identify the mechanisms related mobility change, and c) Identify the conditions under which the intervention is effective. To meet these objectives, 300 regular car users living in Grenoble will be recruited and randomized in one of two arms: 1. experimental group that will receive the InterMob intervention: six months of free public transport/access to a bicycle, and behavior change techniques (personalized transport advice, setting of mobility change goals, considering possible obstacles; 6 months of motivational messages to prompt goal setting and self-monitoring). 2. active control group that will receive information about air pollution (discussion about the health consequences of air pollution, the association between air pollution and car use; 6 months of messages to prompt air pollution monitoring.) Follow-up measures will be carried out until 24 months after the beginning of the study (8-day measurement sessions). Five sessions will involve wearing a GPS/accelerometer, and an air pollution sensor. Participants will complete mobility logs and questionnaires measuring the psychological mechanisms related to their mobility (habits, intentions, self-efficacy), and socio-economical characteristics (number of children, accessibility) during the 8 sessions. The investigators hypothesize that the participants allocated to experimental group will reduce the car use and increase the use of alternative modes to the car (biking, walking, public transport, and carpooling) more than the participants of the control group, and that these changes will remain. The investigators hypothesize that mobility changes will be mediated by intention and self-efficacy. The investigators hypothesize that the efficacy of the intervention will be moderated by socio-spatial factors (number of children, travel distances) and psychological factors (self-control). The main criterion will be car use reduction and the use of alternative modes to the car. In addition, the investigators will assess physical activity (minutes of moderate-to-vigorous physical activity), the exposure to air pollution, the quality of life and the carbon footprint associated to transport.

NCT ID: NCT01257165 Withdrawn - Automobile Driving Clinical Trials

Driving Simulator Performance After Intake of Zopiclone Sleeping Pills

Start date: August 2012
Phase: N/A
Study type: Interventional

Zopiclone, a widely used hypnotic drug, is frequently found in blood samples taken from drivers suspected of driving under the influence. In this study, the investigators aim to correlate zopiclone serum concentrations with degrees of driving impairment in healthy volunteers by use of a validated driving simulator. The investigators also aim to compare their results with the results from a previous study that investigated zopiclone impairment of cognitive and psychometric tests.

NCT ID: NCT00967421 Completed - Automobile Driving Clinical Trials

Development of a Valid Test Battery for Assessing Driving Ability When Influenced by Drugs.

VALIDAD
Start date: September 2009
Phase: N/A
Study type: Interventional

The purpose of the validation study is to develop a valid test battery for assessing driving ability in a driving simulator when influenced by drugs. Ethanol has known, well-documented and well-characterized effects on driving behaviour and accident risk, and will be used to assess the simulator test scenarios' sensitivity to drug effects. Once the test scenarios have been refined and their ability to predict driving accident risk have been validated, we plan to use the simulator to assess driving ability under the influence of different drugs suspected to produce driving impairment.